ESTHER ISAKOVA: Open Payments
NPI 1669942793 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,393 in 97 payments from 20 companies in 2025. Trend: 2023 $629 · 2024 $1,029 · 2025 $2,393
Food & beverage: $2,293Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $328 |
| UCB, Inc. | 12 | $296 |
| Galderma Laboratories, L.P. | 14 | $276 |
| Regeneron Healthcare Solutions, Inc. | 9 | $239 |
| ABBVIE INC. | 10 | $212 |
| Lilly USA, LLC | 5 | $189 |
| Journey Medical Corporation | 1 | $159 |
| Novartis Pharmaceuticals Corporation | 5 | $120 |
| Organon LLC | 9 | $95 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $91 |
Products named: TREMFYA, Bimzelx, DUPIXENT, NEMLUVIO, SKYRIZI, EBGLYSS, Xolair, LIBTAYO.
Industry payments across AZ — which companies pay providers there.
